EyeGate Pharmaceuticals
Earnings Date & Report
Last updated:
EyeGate Pharmaceuticals’s last earnings date was on 8 Nov 2021.
EyeGate Pharmaceuticals stock Earnings report, Estimates & History
| 2016-11-01 | -0.46 | -0.36 |
|---|---|---|
| 2017-02-23 | -0.42 | -0.38 |
| 2017-05-05 | -0.39 | -0.28 |
| 2017-08-04 | -0.2 | -0.28 |
| 2017-11-14 | -3.22 | -3.6 |
| 2018-03-02 | -3.6 | -2.25 |
| 2018-05-11 | -3.6 | -2.1 |
| 2018-08-03 | -2.1 | -1.05 |
| 2018-11-13 | -1.2 | -1.05 |
| 2019-03-01 | -0.9 | -0.75 |
| 2019-05-08 | -0.75 | 0.15 |
| 2019-08-08 | -0.75 | -0.6 |
| 2020-03-04 | -0.81 | -0.71 |
| 2020-08-06 | -0.43 | -0.38 |
| 2021-03-25 | -0.44 | -0.52 |
| 2021-05-12 | -0.38 | -0.37 |
| 2021-08-12 | -0.42 | -0.35 |
Estimated - a value of Apple’s earnings per share estimated by analysts based on its past and current financial statements.
Reported - a real value of Apple’s earnings per share reported by the company.
EyeGate Pharmaceuticals stock earnings history by quarter
| Date | Estimated EPS | Reported EPS | Estimated revenue | Actual revenue | Earnings call | |
|---|---|---|---|---|---|---|
| 8 Nov 2021 | N/A | -$0.34 | N/A | N/A | N/A | |
| 12 Aug 2021 | Beat | -$0.42 | -$0.35 | N/A | N/A | |
| 12 May 2021 | Beat | -$0.38 | -$0.37 | N/A | N/A | |
| 25 Mar 2021 | Missed | -$0.44 | -$0.52 | N/A | 12.05K | |
| 6 Aug 2020 | Beat | -$0.43 | -$0.38 | N/A | N/A | |
| 6 May 2020 | N/A | N/A | N/A | N/A | N/A | |
| 4 Mar 2020 | Beat | -$0.81 | -$0.71 | N/A | N/A | |
| 7 Nov 2019 | N/A | N/A | N/A | N/A | N/A | |
| 8 Aug 2019 | Beat | -$0.75 | -$0.6 | N/A | N/A | |
| 8 May 2019 | Beat | -$0.75 | $0.15 | 13.43M | 2.68M | |
| 1 Mar 2019 | Beat | -$0.9 | -$0.75 | N/A | N/A | |
| 13 Nov 2018 | Beat | -$1.2 | -$1.05 | 359.42K | 314.5K | |
| 3 Aug 2018 | Beat | -$2.1 | -$1.05 | 480K | 242.01K | |
| 11 May 2018 | Beat | -$3.6 | -$2.1 | 1.88M | 1.09M | |
| 2 Mar 2018 | Beat | -$3.6 | -$2.25 | N/A | N/A | |
| 14 Nov 2017 | Missed | -$3.22 | -$3.6 | 62.61K | 74.69K | |
| 4 Aug 2017 | Missed | -$0.2 | -$0.28 | 107.14K | 148.29K | |
| 5 May 2017 | Beat | -$0.39 | -$0.28 | 250.71K | 184.53K | |
| 23 Feb 2017 | Beat | -$0.42 | -$0.38 | 176.84K | 160.37K | |
| 1 Nov 2016 | Beat | -$0.46 | -$0.36 | 345K | 274.28K | |
EyeGate Pharmaceuticals Earnings report FAQs
When is EyeGate Pharmaceuticals's next Earnings date?
The company has not set the next earnings date yet. The latest EyeGate Pharmaceuticals's earnings date was on 6 Aug 2020.
What are earnings?
Earnings are the net income of a company after all taxes and expenses have been deducted. They are the main figure for determining the price of a company's shares.
What does EPS stand for?
EPS stands for earnings per share, which is the basic measure of a company's earnings. It indicates how much money each share earned for the company.
How to calculate earnings per share?
Earnings per share (EPS) can be calculated by dividing a company's net income by the number of common shares outstanding. If the company pays preferred dividends, they are first subtracted from the company’s net income.
Formula:
What is earnings per share estimate?
Earnings estimate is analysts’ prediction of a company’s earnings value in the next quarter or fiscal year based on past and current financial statements of a company. It is an important indicator for both current and future investors.